Category Archives: National Standards for Cognitive Testing

National Standards for Cognitive Testing

Market Update: Memory Assessment Tests with Computerized Screening Tools

New computerized memory screening methods begin to move standardized memory health tests into the home and physician’s office. Screening for early, subtle signs of cognitive impairment becomes important as pharmaceutical companies shift focus to Alzheimer’s drug candidates that may prevent or slow buildup of amyloid protein in the brain. Purchase Report   MyBrainTest.org, a research… Read More »

Cognitive Screening & Testing Report Released

Computerized Cognitive Assessment Products – Neurocognitive Screening for ADHD, Memory Loss, Alzheimer’s, Dementia, Traumatic Brain Injury Since our last report in 2011, the market for computerized cognitive assessment, screening and testing has continued to expand. Key drivers for this market and growing technology product base include: An Aging Global Population: 500 million people in the… Read More »

Early Detection Tests for Alzheimer’s Disease: Introduction

Rising Dementia Rates are a Global Health Trend A positive aspect of rising living standards in most of the world has been a significant improvement in worldwide average life expectancies, increasing from 52 years in 1960 to 69 years in 2009. Regional differences are even more striking — the average life expectancy for a person… Read More »

Detecting Alzheimer’s Disease 20 Years Before Symptoms Appear

A research team at Washington University School of Medicine just published the results of a study that looked at a number of cognitive changes and biomarkers that can be used to predict the risk of Alzheimer’s Disease long before symptoms appear – in some cases up to 20 years before symptom onset. The study, published… Read More »

New Progress on a Blood Test for Alzheimer’s Disease

The PLoS ONE science journal published an interesting study performed by the Brain and Aging Research Program at the University of New South Wales in Sydney, Australia. The study sampled apolipoprotein levels in blood samples from over 600 older adults participating in the ongoing Sydney Memory and Aging Study. Apolipoproteins are proteins that transport cholesterol… Read More »

The Pros and Cons of Amyvid for Amyloid Beta Imaging

A topic that received a lot of attention at the University of California San Diego School of Medicine update on Alzheimer’s research was the use of Eli Lilly’s Amyvid for detection of amyloid beta deposits in the brain, one of the physical signatures of Alzheimer’s Disease. Dr. Gil Rabinovici, MD, a physician and researcher at… Read More »